课题基金 / 基金详情

Mechanisms of immune dysregulation in human PI3Kgamma deficiency

Mechanisms of immune dysregulation in human PI3Kgamma deficiency
人类 PI3Kgamma 缺乏症免疫失调的机制
批准号:
10178863
负责人:
Carrie L. Lucas
金额:
$25.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-14 至 2021-12-31
关键词:
18 year old2019-nCoV5 year oldAbdominal PainAddressAdultAffectAgeAntibodiesAntiviral AgentsAutoantibodiesAutomobile DrivingBiologicalBiological AssayBloodBlood VesselsBlood specimenCOVID-19CaringCase StudyCell Surface ProteinsCellsCenters for Disease Control and Prevention (U.S.)ChildChildhoodConsentCritical IllnessDNA LibraryDataDefectDiseaseElderlyEpidemiologyEventExanthemaExhibitsExposure toFeverGenesGeneticGenetic Predisposition to DiseaseGenomicsGeographic LocationsGleanGoalsHealthHeartHereditary DiseaseHumanHuman BiologyHuman GeneticsHypoxiaImmuneImmune System DiseasesImmune responseImmunityImmunologicsIndividualInfectionInflammationInflammatoryInflammatory ResponseInvestigationItalyKnowledgeLeukocytesLung diseasesMeasuresMediatingModalityMolecularMucocutaneous Lymph Node SyndromeNew YorkOnly ChildPIK3CG genePathogenesisPathologyPathway interactionsPatientsPediatricsPhenotypePneumoniaPopulationPredispositionPrevalencePublishingReportingResearch PersonnelRoleSalivaSamplingSerologicalSerumSerum ProteinsSeverity of illnessShockSingle-Gene DefectSymptomsSyndromeTechnologyTeenagersTestingTissuesValidationVirusVirus DiseasesVulnerable Populationsadaptive immune responseaptamerautoreactivitybasecell typeclinically relevantcohortcollegecoronavirus diseasedesignexome sequencinghigh dimensionalityimmunopathologyinfection rateinsightinterestnovelnovel coronaviruspandemic diseasepediatric patientsperipheral bloodrespiratorysingle-cell RNA sequencingsystemic inflammatory responsetranscriptometreatment strategy

项目摘要

项目成果

Carrie L. Lucas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Many severe immune diseases in young patients with infection susceptibility and/or immune-mediated tissue damage are caused by a single-gene defect resulting in an inborn error of immunity. We have a long- standing interest in intensive investigation of severe immune diseases of childhood. Our approach is to pursue rigorous genetic and immunologic studies that define the genes, cell types, and pathways underlying pathology to glean clinically relevant insights into fundamental human biology directly from patients. Currently, the genetic, molecular, and cellular drivers of susceptibility and pathogenesis in rare cases of severe SARS-CoV2-related disease in young, otherwise healthy individuals are unknown. Defining these drivers will not only address the urgent health needs of children and teenagers afflicted with the recently surging ‘multisystem inflammatory syndrome in children’ (MIS-C) and severe respiratory manifestations associated with SARS-CoV2 infection but will also provide fundamental knowledge about immunopathology mechanisms that are a general feature of COVID-19 across the age spectrum. We have built an growing cohort of young COVID-19 patients and banked DNA, cells, and serum from saliva and peripheral blood samples to enable us to tackle this urgent crisis. Our preliminary data demonstrate feasibility to obtain suitable samples for multi-dimensional analysis of leukocytes from these patients and also raise testable hypotheses about the initiating and triggering events in MIS-C. Using primary human cells and cutting-edge technologies, two specific aims will be pursued. Aim 1) To define genetic susceptibility to severe COVID-19 in young, otherwise healthy subjects. Aim 2) To elucidate immune mechanisms mediating severe inflammatory responses in these children and teenagers. The results of these investigations will provide significant insights into COVID-19 genetics and inflammation and will lay the groundwork to help advance our understanding and treatment strategies for this world-wide pandemic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
  • 批准号:
    10393682
  • 项目类别:
  • 资助金额:
    $59.68万
  • 财政年份:
    2021
  • 负责人:
    Carrie L. Lucas
  • 依托单位:
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
  • 批准号:
    10211252
  • 项目类别:
  • 资助金额:
    $57.13万
  • 财政年份:
    2021
  • 负责人:
    Carrie L. Lucas
  • 依托单位:
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
  • 批准号:
    10589909
  • 项目类别:
  • 资助金额:
    $59.61万
  • 财政年份:
    2021
  • 负责人:
    Carrie L. Lucas
  • 依托单位:
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
  • 批准号:
    9896405
  • 项目类别:
  • 资助金额:
    $20.94万
  • 财政年份:
    2020
  • 负责人:
    Carrie L. Lucas
  • 依托单位:
国内基金
海外基金
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2021
  • 负责人:
    郭晓宇
  • 依托单位:
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
  • 批准号:
    82030002
  • 项目类别:
    专项基金项目
  • 资助金额:
    135万元
  • 批准年份:
    2020
  • 负责人:
    曹彬
  • 依托单位:
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    140万元
  • 批准年份:
    2020
  • 负责人:
    夏雪山
  • 依托单位: